Amolyt Pharma develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Their ambition is to become a leading rare disease company with U.S. and European operations to support global development of our products.
Amolyt Pharma develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Their ambition is to become a leading rare disease company with U.S. and European operations to support global development of our products.
Amolyt Pharma develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Their ambition is to become a leading rare disease company with U.S. and European operations to support global development of our products.